Bioactive Milk Peptides and Blood Pressure

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stage 1 Hypertension Cardiovascular Diseases Hypertension Vascular Diseases

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Valio Ltd

Helsinki, Uusimaa, 00370, Finland

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 30-60 years
systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement
apparently healthy

Exclusion criteria

antihypertensive and lipid-lowering drugs
unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension
BMI > 32 kg/m2
milk allergy
smoking
alcohol abuse
pregnancy, lactation
simultaneous participation in other clinical trial

Treatment and study plan

Milk peptides and plant sterols

Dietary Supplement

Placebo

Other

Primary outcomes

Blood pressure

Sponsors and collaborators

Lead sponsor

Valio Ltd

Industry

Collaborators

University of Helsinki

Registry information

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Dec 14, 2009
Registry last updated: Dec 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed